ChemoCentryx, Inc. (CCXI) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
High 13.01 at 4:15 pm ET, low 12.08 at 8:15 am ET.
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California.
No case yet. It builds on the next filing, report or 13F period.
Churchill Capital Corp XI has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 3569, General Industrial Machinery & Equipment, NEC, from each company's own filings. Largest first.
72 managers report a position worth $496.0M between them, and 19 of them hold 80% of it.
ChemoCentryx, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · General Industrial Machinery & Equipment, NEC
tall tick = annual report · 1 on record
CCXI (ChemoCentryx, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.